Frontlight ResearchEarly access
Trial site
National Ophthalmic Research Institute
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration9 trials
- Diabetic eye disease6 trials
- Phase
- Phase 39 trials
- Phase 24 trials
- Phase 1/21 trial
- Status
- Active, not recruiting7 trials
- Completed6 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- Jaeb Center for Health Research3 trials
- Genentech, Inc.2 trials
- Annexon, Inc.1 trial
- Apellis Pharmaceuticals, Inc.1 trial
- and 5 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Active, not recruiting
Active, not recruiting
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
Active, not recruiting
Active, not recruiting
Closed trials
Recruiting
Terminated
Completed
Completed
Completed
A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
Completed
Completed
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Site data: ClinicalTrials.govUpdated 17 Nov 2026